database,exposure,outcomeCategory,Disease,denomPatid,denomIndexExp,timeWindow,numer,prevPct
MPCD,DMARD,Cancer,Hematologic Cancer,145,165,12 months,1,0.6060606061
MPCD,DMARD,Cancer,Hematologic Cancer,145,165,24 months,1,0.6060606061
MPCD,DMARD,Cancer,Hematologic Cancer,145,165,36 months,1,0.6060606061
MPCD,DMARD,Cancer,Hematologic Cancer,145,165,AS cohort entry to exposure,1,0.6060606061
MPCD,DMARD,Cancer,Solid Cancer,145,165,12 months,6,3.6363636364
MPCD,DMARD,Cancer,Solid Cancer,145,165,24 months,8,4.8484848485
MPCD,DMARD,Cancer,Solid Cancer,145,165,36 months,8,4.8484848485
MPCD,DMARD,Cancer,Solid Cancer,145,165,AS cohort entry to exposure,5,3.0303030303
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,145,165,12 months,2,1.2121212121
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,145,165,24 months,2,1.2121212121
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,145,165,36 months,2,1.2121212121
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,145,165,AS cohort entry to exposure,0,0
MPCD,DMARD,Infection,Hospitalized infection,145,165,12 months,2,1.2121212121
MPCD,DMARD,Infection,Hospitalized infection,145,165,24 months,5,3.0303030303
MPCD,DMARD,Infection,Hospitalized infection,145,165,36 months,7,4.2424242424
MPCD,DMARD,Infection,Hospitalized infection,145,165,AS cohort entry to exposure,3,1.8181818182
MPCD,DMARD,Infection,Opportunistic infection,145,165,12 months,1,0.6060606061
MPCD,DMARD,Infection,Opportunistic infection,145,165,24 months,4,2.4242424242
MPCD,DMARD,Infection,Opportunistic infection,145,165,36 months,8,4.8484848485
MPCD,DMARD,Infection,Opportunistic infection,145,165,AS cohort entry to exposure,1,0.6060606061
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,145,165,12 months,7,4.2424242424
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,145,165,24 months,9,5.4545454545
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,145,165,36 months,9,5.4545454545
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,145,165,AS cohort entry to exposure,7,4.2424242424
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,145,165,12 months,4,2.4242424242
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,145,165,24 months,4,2.4242424242
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,145,165,36 months,4,2.4242424242
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,145,165,AS cohort entry to exposure,2,1.2121212121
MPCD,DMARD,Kidney disease,IgA nephropathy,145,165,12 months,1,0.6060606061
MPCD,DMARD,Kidney disease,IgA nephropathy,145,165,24 months,1,0.6060606061
MPCD,DMARD,Kidney disease,IgA nephropathy,145,165,36 months,1,0.6060606061
MPCD,DMARD,Kidney disease,IgA nephropathy,145,165,AS cohort entry to exposure,1,0.6060606061
MPCD,DMARD,Lung disease,Restrictive lung disease ,145,165,12 months,0,0
MPCD,DMARD,Lung disease,Restrictive lung disease ,145,165,24 months,0,0
MPCD,DMARD,Lung disease,Restrictive lung disease ,145,165,36 months,1,0.6060606061
MPCD,DMARD,Lung disease,Restrictive lung disease ,145,165,AS cohort entry to exposure,0,0
MPCD,DMARD,Osteoporotic fracture,Clinical vertebral fracture,145,165,12 months,1,0.6060606061
MPCD,DMARD,Osteoporotic fracture,Clinical vertebral fracture,145,165,24 months,1,0.6060606061
MPCD,DMARD,Osteoporotic fracture,Clinical vertebral fracture,145,165,36 months,1,0.6060606061
MPCD,DMARD,Osteoporotic fracture,Clinical vertebral fracture,145,165,AS cohort entry to exposure,1,0.6060606061
MPCD,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,145,165,12 months,2,1.2121212121
MPCD,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,145,165,24 months,4,2.4242424242
MPCD,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,145,165,36 months,6,3.6363636364
MPCD,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,145,165,AS cohort entry to exposure,1,0.6060606061
MPCD,DMARD,PsO/PsA,Psoriasis,145,165,12 months,3,1.8181818182
MPCD,DMARD,PsO/PsA,Psoriasis,145,165,24 months,3,1.8181818182
MPCD,DMARD,PsO/PsA,Psoriasis,145,165,36 months,5,3.0303030303
MPCD,DMARD,PsO/PsA,Psoriasis,145,165,AS cohort entry to exposure,3,1.8181818182
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,145,165,12 months,5,3.0303030303
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,145,165,24 months,7,4.2424242424
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,145,165,36 months,8,4.8484848485
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,145,165,AS cohort entry to exposure,5,3.0303030303
MPCD,DMARD,Uveitis,Uveitis,145,165,12 months,11,6.6666666667
MPCD,DMARD,Uveitis,Uveitis,145,165,24 months,13,7.8787878788
MPCD,DMARD,Uveitis,Uveitis,145,165,36 months,14,8.4848484848
MPCD,DMARD,Uveitis,Uveitis,145,165,AS cohort entry to exposure,10,6.0606060606
MPCD,NSAID,Cancer,Solid Cancer,265,355,12 months,7,1.9718309859
MPCD,NSAID,Cancer,Solid Cancer,265,355,24 months,10,2.8169014085
MPCD,NSAID,Cancer,Solid Cancer,265,355,36 months,11,3.0985915493
MPCD,NSAID,Cancer,Solid Cancer,265,355,AS cohort entry to exposure,7,1.9718309859
MPCD,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,265,355,12 months,1,0.2816901408
MPCD,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,265,355,24 months,1,0.2816901408
MPCD,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,265,355,36 months,1,0.2816901408
MPCD,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,265,355,AS cohort entry to exposure,0,0
MPCD,NSAID,Cardiac disease,Conduction Block,265,355,12 months,3,0.8450704225
MPCD,NSAID,Cardiac disease,Conduction Block,265,355,24 months,3,0.8450704225
MPCD,NSAID,Cardiac disease,Conduction Block,265,355,36 months,3,0.8450704225
MPCD,NSAID,Cardiac disease,Conduction Block,265,355,AS cohort entry to exposure,1,0.2816901408
MPCD,NSAID,Infection,Hospitalized infection,265,355,12 months,1,0.2816901408
MPCD,NSAID,Infection,Hospitalized infection,265,355,24 months,1,0.2816901408
MPCD,NSAID,Infection,Hospitalized infection,265,355,36 months,1,0.2816901408
MPCD,NSAID,Infection,Hospitalized infection,265,355,AS cohort entry to exposure,0,0
MPCD,NSAID,Infection,Opportunistic infection,265,355,12 months,0,0
MPCD,NSAID,Infection,Opportunistic infection,265,355,24 months,0,0
MPCD,NSAID,Infection,Opportunistic infection,265,355,36 months,0,0
MPCD,NSAID,Infection,Opportunistic infection,265,355,AS cohort entry to exposure,2,0.5633802817
MPCD,NSAID,Inflammatory bowel disease,Crohn’s Disease,265,355,12 months,4,1.1267605634
MPCD,NSAID,Inflammatory bowel disease,Crohn’s Disease,265,355,24 months,6,1.6901408451
MPCD,NSAID,Inflammatory bowel disease,Crohn’s Disease,265,355,36 months,7,1.9718309859
MPCD,NSAID,Inflammatory bowel disease,Crohn’s Disease,265,355,AS cohort entry to exposure,5,1.4084507042
MPCD,NSAID,Inflammatory bowel disease,Ulcerative Colitis,265,355,12 months,4,1.1267605634
MPCD,NSAID,Inflammatory bowel disease,Ulcerative Colitis,265,355,24 months,5,1.4084507042
MPCD,NSAID,Inflammatory bowel disease,Ulcerative Colitis,265,355,36 months,5,1.4084507042
MPCD,NSAID,Inflammatory bowel disease,Ulcerative Colitis,265,355,AS cohort entry to exposure,6,1.6901408451
MPCD,NSAID,Kidney disease,IgA nephropathy,265,355,12 months,1,0.2816901408
MPCD,NSAID,Kidney disease,IgA nephropathy,265,355,24 months,2,0.5633802817
MPCD,NSAID,Kidney disease,IgA nephropathy,265,355,36 months,2,0.5633802817
MPCD,NSAID,Kidney disease,IgA nephropathy,265,355,AS cohort entry to exposure,1,0.2816901408
MPCD,NSAID,Lung disease,Restrictive lung disease ,265,355,12 months,4,1.1267605634
MPCD,NSAID,Lung disease,Restrictive lung disease ,265,355,24 months,7,1.9718309859
MPCD,NSAID,Lung disease,Restrictive lung disease ,265,355,36 months,9,2.5352112676
MPCD,NSAID,Lung disease,Restrictive lung disease ,265,355,AS cohort entry to exposure,1,0.2816901408
MPCD,NSAID,Neurological Disease,Spinal Cord compression,265,355,12 months,2,0.5633802817
MPCD,NSAID,Neurological Disease,Spinal Cord compression,265,355,24 months,3,0.8450704225
MPCD,NSAID,Neurological Disease,Spinal Cord compression,265,355,36 months,3,0.8450704225
MPCD,NSAID,Neurological Disease,Spinal Cord compression,265,355,AS cohort entry to exposure,1,0.2816901408
MPCD,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,265,355,12 months,9,2.5352112676
MPCD,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,265,355,24 months,10,2.8169014085
MPCD,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,265,355,36 months,11,3.0985915493
MPCD,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,265,355,AS cohort entry to exposure,7,1.9718309859
MPCD,NSAID,PsO/PsA,Psoriasis,265,355,12 months,3,0.8450704225
MPCD,NSAID,PsO/PsA,Psoriasis,265,355,24 months,3,0.8450704225
MPCD,NSAID,PsO/PsA,Psoriasis,265,355,36 months,3,0.8450704225
MPCD,NSAID,PsO/PsA,Psoriasis,265,355,AS cohort entry to exposure,3,0.8450704225
MPCD,NSAID,PsO/PsA,Psoriatic arthritis,265,355,12 months,3,0.8450704225
MPCD,NSAID,PsO/PsA,Psoriatic arthritis,265,355,24 months,3,0.8450704225
MPCD,NSAID,PsO/PsA,Psoriatic arthritis,265,355,36 months,4,1.1267605634
MPCD,NSAID,PsO/PsA,Psoriatic arthritis,265,355,AS cohort entry to exposure,3,0.8450704225
MPCD,NSAID,Uveitis,Uveitis,265,355,12 months,27,7.6056338028
MPCD,NSAID,Uveitis,Uveitis,265,355,24 months,31,8.7323943662
MPCD,NSAID,Uveitis,Uveitis,265,355,36 months,31,8.7323943662
MPCD,NSAID,Uveitis,Uveitis,265,355,AS cohort entry to exposure,24,6.7605633803
MPCD,No exposure,Cancer,Hematologic Cancer,512,512,12 months,2,0.390625
MPCD,No exposure,Cancer,Hematologic Cancer,512,512,24 months,3,0.5859375
MPCD,No exposure,Cancer,Hematologic Cancer,512,512,36 months,5,0.9765625
MPCD,No exposure,Cancer,Hematologic Cancer,512,512,AS cohort entry to exposure,0,0
MPCD,No exposure,Cancer,Solid Cancer,512,512,12 months,27,5.2734375
MPCD,No exposure,Cancer,Solid Cancer,512,512,24 months,38,7.421875
MPCD,No exposure,Cancer,Solid Cancer,512,512,36 months,45,8.7890625
MPCD,No exposure,Cancer,Solid Cancer,512,512,AS cohort entry to exposure,4,0.78125
MPCD,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,512,512,12 months,13,2.5390625
MPCD,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,512,512,24 months,15,2.9296875
MPCD,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,512,512,36 months,18,3.515625
MPCD,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,512,512,AS cohort entry to exposure,1,0.1953125
MPCD,No exposure,Cardiac disease,Conduction Block,512,512,12 months,5,0.9765625
MPCD,No exposure,Cardiac disease,Conduction Block,512,512,24 months,8,1.5625
MPCD,No exposure,Cardiac disease,Conduction Block,512,512,36 months,8,1.5625
MPCD,No exposure,Cardiac disease,Conduction Block,512,512,AS cohort entry to exposure,0,0
MPCD,No exposure,Cardiac disease,Myocardial infarction,512,512,12 months,1,0.1953125
MPCD,No exposure,Cardiac disease,Myocardial infarction,512,512,24 months,4,0.78125
MPCD,No exposure,Cardiac disease,Myocardial infarction,512,512,36 months,4,0.78125
MPCD,No exposure,Cardiac disease,Myocardial infarction,512,512,AS cohort entry to exposure,0,0
MPCD,No exposure,Infection,Hospitalized infection,512,512,12 months,5,0.9765625
MPCD,No exposure,Infection,Hospitalized infection,512,512,24 months,13,2.5390625
MPCD,No exposure,Infection,Hospitalized infection,512,512,36 months,16,3.125
MPCD,No exposure,Infection,Hospitalized infection,512,512,AS cohort entry to exposure,0,0
MPCD,No exposure,Infection,Opportunistic infection,512,512,12 months,2,0.390625
MPCD,No exposure,Infection,Opportunistic infection,512,512,24 months,4,0.78125
MPCD,No exposure,Infection,Opportunistic infection,512,512,36 months,6,1.171875
MPCD,No exposure,Infection,Opportunistic infection,512,512,AS cohort entry to exposure,0,0
MPCD,No exposure,Inflammatory bowel disease,Crohn’s Disease,512,512,12 months,14,2.734375
MPCD,No exposure,Inflammatory bowel disease,Crohn’s Disease,512,512,24 months,19,3.7109375
MPCD,No exposure,Inflammatory bowel disease,Crohn’s Disease,512,512,36 months,23,4.4921875
MPCD,No exposure,Inflammatory bowel disease,Crohn’s Disease,512,512,AS cohort entry to exposure,3,0.5859375
MPCD,No exposure,Inflammatory bowel disease,Ulcerative Colitis,512,512,12 months,8,1.5625
MPCD,No exposure,Inflammatory bowel disease,Ulcerative Colitis,512,512,24 months,10,1.953125
MPCD,No exposure,Inflammatory bowel disease,Ulcerative Colitis,512,512,36 months,12,2.34375
MPCD,No exposure,Inflammatory bowel disease,Ulcerative Colitis,512,512,AS cohort entry to exposure,0,0
MPCD,No exposure,Kidney disease,Amyloidosis,512,512,12 months,1,0.1953125
MPCD,No exposure,Kidney disease,Amyloidosis,512,512,24 months,2,0.390625
MPCD,No exposure,Kidney disease,Amyloidosis,512,512,36 months,3,0.5859375
MPCD,No exposure,Kidney disease,Amyloidosis,512,512,AS cohort entry to exposure,0,0
MPCD,No exposure,Kidney disease,IgA nephropathy,512,512,12 months,0,0
MPCD,No exposure,Kidney disease,IgA nephropathy,512,512,24 months,0,0
MPCD,No exposure,Kidney disease,IgA nephropathy,512,512,36 months,2,0.390625
MPCD,No exposure,Kidney disease,IgA nephropathy,512,512,AS cohort entry to exposure,0,0
MPCD,No exposure,Kidney disease,Nephrotic syndrome,512,512,12 months,0,0
MPCD,No exposure,Kidney disease,Nephrotic syndrome,512,512,24 months,1,0.1953125
MPCD,No exposure,Kidney disease,Nephrotic syndrome,512,512,36 months,1,0.1953125
MPCD,No exposure,Kidney disease,Nephrotic syndrome,512,512,AS cohort entry to exposure,0,0
MPCD,No exposure,Lung disease,Apical Pulmonary fibrosis,512,512,12 months,0,0
MPCD,No exposure,Lung disease,Apical Pulmonary fibrosis,512,512,24 months,1,0.1953125
MPCD,No exposure,Lung disease,Apical Pulmonary fibrosis,512,512,36 months,1,0.1953125
MPCD,No exposure,Lung disease,Apical Pulmonary fibrosis,512,512,AS cohort entry to exposure,0,0
MPCD,No exposure,Lung disease,Restrictive lung disease ,512,512,12 months,9,1.7578125
MPCD,No exposure,Lung disease,Restrictive lung disease ,512,512,24 months,11,2.1484375
MPCD,No exposure,Lung disease,Restrictive lung disease ,512,512,36 months,12,2.34375
MPCD,No exposure,Lung disease,Restrictive lung disease ,512,512,AS cohort entry to exposure,1,0.1953125
MPCD,No exposure,Neurological Disease,Cauda Equina syndrome,512,512,12 months,1,0.1953125
MPCD,No exposure,Neurological Disease,Cauda Equina syndrome,512,512,24 months,2,0.390625
MPCD,No exposure,Neurological Disease,Cauda Equina syndrome,512,512,36 months,2,0.390625
MPCD,No exposure,Neurological Disease,Cauda Equina syndrome,512,512,AS cohort entry to exposure,0,0
MPCD,No exposure,Neurological Disease,Spinal Cord compression,512,512,12 months,0,0
MPCD,No exposure,Neurological Disease,Spinal Cord compression,512,512,24 months,0,0
MPCD,No exposure,Neurological Disease,Spinal Cord compression,512,512,36 months,1,0.1953125
MPCD,No exposure,Neurological Disease,Spinal Cord compression,512,512,AS cohort entry to exposure,0,0
MPCD,No exposure,Osteoporotic fracture,Clinical vertebral fracture,512,512,12 months,11,2.1484375
MPCD,No exposure,Osteoporotic fracture,Clinical vertebral fracture,512,512,24 months,15,2.9296875
MPCD,No exposure,Osteoporotic fracture,Clinical vertebral fracture,512,512,36 months,16,3.125
MPCD,No exposure,Osteoporotic fracture,Clinical vertebral fracture,512,512,AS cohort entry to exposure,1,0.1953125
MPCD,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,512,512,12 months,14,2.734375
MPCD,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,512,512,24 months,25,4.8828125
MPCD,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,512,512,36 months,26,5.078125
MPCD,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,512,512,AS cohort entry to exposure,2,0.390625
MPCD,No exposure,PsO/PsA,Psoriasis,512,512,12 months,10,1.953125
MPCD,No exposure,PsO/PsA,Psoriasis,512,512,24 months,13,2.5390625
MPCD,No exposure,PsO/PsA,Psoriasis,512,512,36 months,14,2.734375
MPCD,No exposure,PsO/PsA,Psoriasis,512,512,AS cohort entry to exposure,3,0.5859375
MPCD,No exposure,PsO/PsA,Psoriatic arthritis,512,512,12 months,15,2.9296875
MPCD,No exposure,PsO/PsA,Psoriatic arthritis,512,512,24 months,18,3.515625
MPCD,No exposure,PsO/PsA,Psoriatic arthritis,512,512,36 months,22,4.296875
MPCD,No exposure,PsO/PsA,Psoriatic arthritis,512,512,AS cohort entry to exposure,6,1.171875
MPCD,No exposure,Uveitis,Uveitis,512,512,12 months,40,7.8125
MPCD,No exposure,Uveitis,Uveitis,512,512,24 months,53,10.3515625
MPCD,No exposure,Uveitis,Uveitis,512,512,36 months,54,10.546875
MPCD,No exposure,Uveitis,Uveitis,512,512,AS cohort entry to exposure,9,1.7578125
MPCD,TNF,Cancer,Hematologic Cancer,575,670,12 months,1,0.1492537313
MPCD,TNF,Cancer,Hematologic Cancer,575,670,24 months,2,0.2985074627
MPCD,TNF,Cancer,Hematologic Cancer,575,670,36 months,2,0.2985074627
MPCD,TNF,Cancer,Hematologic Cancer,575,670,AS cohort entry to exposure,1,0.1492537313
MPCD,TNF,Cancer,Solid Cancer,575,670,12 months,15,2.2388059701
MPCD,TNF,Cancer,Solid Cancer,575,670,24 months,21,3.1343283582
MPCD,TNF,Cancer,Solid Cancer,575,670,36 months,23,3.4328358209
MPCD,TNF,Cancer,Solid Cancer,575,670,AS cohort entry to exposure,12,1.7910447761
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,575,670,12 months,13,1.9402985075
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,575,670,24 months,15,2.2388059701
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,575,670,36 months,15,2.2388059701
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,575,670,AS cohort entry to exposure,10,1.4925373134
MPCD,TNF,Cardiac disease,Conduction Block,575,670,12 months,1,0.1492537313
MPCD,TNF,Cardiac disease,Conduction Block,575,670,24 months,1,0.1492537313
MPCD,TNF,Cardiac disease,Conduction Block,575,670,36 months,1,0.1492537313
MPCD,TNF,Cardiac disease,Conduction Block,575,670,AS cohort entry to exposure,0,0
MPCD,TNF,Cardiac disease,Myocardial infarction,575,670,12 months,0,0
MPCD,TNF,Cardiac disease,Myocardial infarction,575,670,24 months,2,0.2985074627
MPCD,TNF,Cardiac disease,Myocardial infarction,575,670,36 months,2,0.2985074627
MPCD,TNF,Cardiac disease,Myocardial infarction,575,670,AS cohort entry to exposure,0,0
MPCD,TNF,Infection,Hospitalized infection,575,670,12 months,4,0.5970149254
MPCD,TNF,Infection,Hospitalized infection,575,670,24 months,7,1.0447761194
MPCD,TNF,Infection,Hospitalized infection,575,670,36 months,9,1.3432835821
MPCD,TNF,Infection,Hospitalized infection,575,670,AS cohort entry to exposure,4,0.5970149254
MPCD,TNF,Infection,Opportunistic infection,575,670,12 months,6,0.8955223881
MPCD,TNF,Infection,Opportunistic infection,575,670,24 months,10,1.4925373134
MPCD,TNF,Infection,Opportunistic infection,575,670,36 months,11,1.6417910448
MPCD,TNF,Infection,Opportunistic infection,575,670,AS cohort entry to exposure,2,0.2985074627
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,575,670,12 months,34,5.0746268657
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,575,670,24 months,38,5.671641791
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,575,670,36 months,41,6.1194029851
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,575,670,AS cohort entry to exposure,28,4.1791044776
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,575,670,12 months,16,2.3880597015
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,575,670,24 months,18,2.6865671642
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,575,670,36 months,18,2.6865671642
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,575,670,AS cohort entry to exposure,15,2.2388059701
MPCD,TNF,Kidney disease,IgA nephropathy,575,670,12 months,2,0.2985074627
MPCD,TNF,Kidney disease,IgA nephropathy,575,670,24 months,2,0.2985074627
MPCD,TNF,Kidney disease,IgA nephropathy,575,670,36 months,2,0.2985074627
MPCD,TNF,Kidney disease,IgA nephropathy,575,670,AS cohort entry to exposure,1,0.1492537313
MPCD,TNF,Kidney disease,Nephrotic syndrome,575,670,12 months,2,0.2985074627
MPCD,TNF,Kidney disease,Nephrotic syndrome,575,670,24 months,2,0.2985074627
MPCD,TNF,Kidney disease,Nephrotic syndrome,575,670,36 months,2,0.2985074627
MPCD,TNF,Kidney disease,Nephrotic syndrome,575,670,AS cohort entry to exposure,0,0
MPCD,TNF,Lung disease,Restrictive lung disease ,575,670,12 months,4,0.5970149254
MPCD,TNF,Lung disease,Restrictive lung disease ,575,670,24 months,7,1.0447761194
MPCD,TNF,Lung disease,Restrictive lung disease ,575,670,36 months,8,1.1940298507
MPCD,TNF,Lung disease,Restrictive lung disease ,575,670,AS cohort entry to exposure,4,0.5970149254
MPCD,TNF,Neurological Disease,Spinal Cord compression,575,670,12 months,1,0.1492537313
MPCD,TNF,Neurological Disease,Spinal Cord compression,575,670,24 months,1,0.1492537313
MPCD,TNF,Neurological Disease,Spinal Cord compression,575,670,36 months,1,0.1492537313
MPCD,TNF,Neurological Disease,Spinal Cord compression,575,670,AS cohort entry to exposure,0,0
MPCD,TNF,Osteoporotic fracture,Clinical vertebral fracture,575,670,12 months,9,1.3432835821
MPCD,TNF,Osteoporotic fracture,Clinical vertebral fracture,575,670,24 months,10,1.4925373134
MPCD,TNF,Osteoporotic fracture,Clinical vertebral fracture,575,670,36 months,10,1.4925373134
MPCD,TNF,Osteoporotic fracture,Clinical vertebral fracture,575,670,AS cohort entry to exposure,6,0.8955223881
MPCD,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,575,670,12 months,11,1.6417910448
MPCD,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,575,670,24 months,14,2.0895522388
MPCD,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,575,670,36 months,14,2.0895522388
MPCD,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,575,670,AS cohort entry to exposure,6,0.8955223881
MPCD,TNF,PsO/PsA,Psoriasis,575,670,12 months,24,3.5820895522
MPCD,TNF,PsO/PsA,Psoriasis,575,670,24 months,30,4.4776119403
MPCD,TNF,PsO/PsA,Psoriasis,575,670,36 months,31,4.6268656716
MPCD,TNF,PsO/PsA,Psoriasis,575,670,AS cohort entry to exposure,15,2.2388059701
MPCD,TNF,PsO/PsA,Psoriatic arthritis,575,670,12 months,36,5.3731343284
MPCD,TNF,PsO/PsA,Psoriatic arthritis,575,670,24 months,46,6.8656716418
MPCD,TNF,PsO/PsA,Psoriatic arthritis,575,670,36 months,50,7.4626865672
MPCD,TNF,PsO/PsA,Psoriatic arthritis,575,670,AS cohort entry to exposure,31,4.6268656716
MPCD,TNF,Uveitis,Uveitis,575,670,12 months,56,8.3582089552
MPCD,TNF,Uveitis,Uveitis,575,670,24 months,62,9.2537313433
MPCD,TNF,Uveitis,Uveitis,575,670,36 months,64,9.552238806
MPCD,TNF,Uveitis,Uveitis,575,670,AS cohort entry to exposure,45,6.7164179104
Marketscan,DMARD,Cancer,Hematologic Cancer,710,777,12 months,6,0.7722007722
Marketscan,DMARD,Cancer,Hematologic Cancer,710,777,24 months,7,0.9009009009
Marketscan,DMARD,Cancer,Hematologic Cancer,710,777,36 months,7,0.9009009009
Marketscan,DMARD,Cancer,Hematologic Cancer,710,777,AS cohort entry to exposure,4,0.5148005148
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,710,777,12 months,4,0.5148005148
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,710,777,24 months,11,1.4157014157
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,710,777,36 months,14,1.8018018018
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,710,777,AS cohort entry to exposure,5,0.6435006435
Marketscan,DMARD,Cancer,Solid Cancer,710,777,12 months,41,5.2767052767
Marketscan,DMARD,Cancer,Solid Cancer,710,777,24 months,43,5.5341055341
Marketscan,DMARD,Cancer,Solid Cancer,710,777,36 months,48,6.1776061776
Marketscan,DMARD,Cancer,Solid Cancer,710,777,AS cohort entry to exposure,35,4.5045045045
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,710,777,12 months,7,0.9009009009
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,710,777,24 months,11,1.4157014157
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,710,777,36 months,15,1.9305019305
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,710,777,AS cohort entry to exposure,6,0.7722007722
Marketscan,DMARD,Cardiac disease,Conduction Block,710,777,12 months,8,1.0296010296
Marketscan,DMARD,Cardiac disease,Conduction Block,710,777,24 months,14,1.8018018018
Marketscan,DMARD,Cardiac disease,Conduction Block,710,777,36 months,14,1.8018018018
Marketscan,DMARD,Cardiac disease,Conduction Block,710,777,AS cohort entry to exposure,7,0.9009009009
Marketscan,DMARD,Cardiac disease,Myocardial infarction,710,777,12 months,0,0
Marketscan,DMARD,Cardiac disease,Myocardial infarction,710,777,24 months,1,0.1287001287
Marketscan,DMARD,Cardiac disease,Myocardial infarction,710,777,36 months,2,0.2574002574
Marketscan,DMARD,Cardiac disease,Myocardial infarction,710,777,AS cohort entry to exposure,1,0.1287001287
Marketscan,DMARD,Infection,Hospitalized infection,710,777,12 months,26,3.3462033462
Marketscan,DMARD,Infection,Hospitalized infection,710,777,24 months,39,5.0193050193
Marketscan,DMARD,Infection,Hospitalized infection,710,777,36 months,42,5.4054054054
Marketscan,DMARD,Infection,Hospitalized infection,710,777,AS cohort entry to exposure,22,2.8314028314
Marketscan,DMARD,Infection,Opportunistic infection,710,777,12 months,11,1.4157014157
Marketscan,DMARD,Infection,Opportunistic infection,710,777,24 months,17,2.1879021879
Marketscan,DMARD,Infection,Opportunistic infection,710,777,36 months,20,2.574002574
Marketscan,DMARD,Infection,Opportunistic infection,710,777,AS cohort entry to exposure,9,1.1583011583
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,710,777,12 months,31,3.9897039897
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,710,777,24 months,33,4.2471042471
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,710,777,36 months,35,4.5045045045
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,710,777,AS cohort entry to exposure,24,3.0888030888
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,710,777,12 months,12,1.5444015444
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,710,777,24 months,16,2.0592020592
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,710,777,36 months,18,2.3166023166
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,710,777,AS cohort entry to exposure,5,0.6435006435
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,710,777,12 months,0,0
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,710,777,24 months,0,0
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,710,777,36 months,1,0.1287001287
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,710,777,AS cohort entry to exposure,0,0
Marketscan,DMARD,Lung disease,Interstitial lung disease,710,777,12 months,2,0.2574002574
Marketscan,DMARD,Lung disease,Interstitial lung disease,710,777,24 months,2,0.2574002574
Marketscan,DMARD,Lung disease,Interstitial lung disease,710,777,36 months,2,0.2574002574
Marketscan,DMARD,Lung disease,Interstitial lung disease,710,777,AS cohort entry to exposure,1,0.1287001287
Marketscan,DMARD,Lung disease,Restrictive lung disease ,710,777,12 months,5,0.6435006435
Marketscan,DMARD,Lung disease,Restrictive lung disease ,710,777,24 months,10,1.287001287
Marketscan,DMARD,Lung disease,Restrictive lung disease ,710,777,36 months,16,2.0592020592
Marketscan,DMARD,Lung disease,Restrictive lung disease ,710,777,AS cohort entry to exposure,7,0.9009009009
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,710,777,12 months,2,0.2574002574
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,710,777,24 months,2,0.2574002574
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,710,777,36 months,3,0.3861003861
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,710,777,AS cohort entry to exposure,1,0.1287001287
Marketscan,DMARD,Osteoporotic fracture,Clinical vertebral fracture,710,777,12 months,5,0.6435006435
Marketscan,DMARD,Osteoporotic fracture,Clinical vertebral fracture,710,777,24 months,6,0.7722007722
Marketscan,DMARD,Osteoporotic fracture,Clinical vertebral fracture,710,777,36 months,8,1.0296010296
Marketscan,DMARD,Osteoporotic fracture,Clinical vertebral fracture,710,777,AS cohort entry to exposure,3,0.3861003861
Marketscan,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,710,777,12 months,6,0.7722007722
Marketscan,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,710,777,24 months,12,1.5444015444
Marketscan,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,710,777,36 months,15,1.9305019305
Marketscan,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,710,777,AS cohort entry to exposure,7,0.9009009009
Marketscan,DMARD,PsO/PsA,Psoriasis,710,777,12 months,26,3.3462033462
Marketscan,DMARD,PsO/PsA,Psoriasis,710,777,24 months,33,4.2471042471
Marketscan,DMARD,PsO/PsA,Psoriasis,710,777,36 months,37,4.7619047619
Marketscan,DMARD,PsO/PsA,Psoriasis,710,777,AS cohort entry to exposure,22,2.8314028314
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,710,777,12 months,46,5.9202059202
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,710,777,24 months,53,6.8211068211
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,710,777,36 months,54,6.9498069498
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,710,777,AS cohort entry to exposure,29,3.7323037323
Marketscan,DMARD,Uveitis,Uveitis,710,777,12 months,56,7.2072072072
Marketscan,DMARD,Uveitis,Uveitis,710,777,24 months,69,8.8803088803
Marketscan,DMARD,Uveitis,Uveitis,710,777,36 months,74,9.5238095238
Marketscan,DMARD,Uveitis,Uveitis,710,777,AS cohort entry to exposure,46,5.9202059202
Marketscan,NSAID,Cancer,Hematologic Cancer,1293,1733,12 months,4,0.230813618
Marketscan,NSAID,Cancer,Hematologic Cancer,1293,1733,24 months,7,0.4039238315
Marketscan,NSAID,Cancer,Hematologic Cancer,1293,1733,36 months,7,0.4039238315
Marketscan,NSAID,Cancer,Hematologic Cancer,1293,1733,AS cohort entry to exposure,7,0.4039238315
Marketscan,NSAID,Cancer,Non Melanoma Skin Cancer,1293,1733,12 months,11,0.6347374495
Marketscan,NSAID,Cancer,Non Melanoma Skin Cancer,1293,1733,24 months,19,1.0963646855
Marketscan,NSAID,Cancer,Non Melanoma Skin Cancer,1293,1733,36 months,21,1.2117714945
Marketscan,NSAID,Cancer,Non Melanoma Skin Cancer,1293,1733,AS cohort entry to exposure,18,1.038661281
Marketscan,NSAID,Cancer,Solid Cancer,1293,1733,12 months,63,3.6353144836
Marketscan,NSAID,Cancer,Solid Cancer,1293,1733,24 months,83,4.7893825736
Marketscan,NSAID,Cancer,Solid Cancer,1293,1733,36 months,87,5.0201961916
Marketscan,NSAID,Cancer,Solid Cancer,1293,1733,AS cohort entry to exposure,62,3.5776110791
Marketscan,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1293,1733,12 months,8,0.461627236
Marketscan,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1293,1733,24 months,12,0.692440854
Marketscan,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1293,1733,36 months,12,0.692440854
Marketscan,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1293,1733,AS cohort entry to exposure,10,0.577034045
Marketscan,NSAID,Cardiac disease,Conduction Block,1293,1733,12 months,22,1.269474899
Marketscan,NSAID,Cardiac disease,Conduction Block,1293,1733,24 months,29,1.6733987305
Marketscan,NSAID,Cardiac disease,Conduction Block,1293,1733,36 months,34,1.961915753
Marketscan,NSAID,Cardiac disease,Conduction Block,1293,1733,AS cohort entry to exposure,16,0.923254472
Marketscan,NSAID,Cardiac disease,Myocardial infarction,1293,1733,12 months,2,0.115406809
Marketscan,NSAID,Cardiac disease,Myocardial infarction,1293,1733,24 months,5,0.2885170225
Marketscan,NSAID,Cardiac disease,Myocardial infarction,1293,1733,36 months,7,0.4039238315
Marketscan,NSAID,Cardiac disease,Myocardial infarction,1293,1733,AS cohort entry to exposure,4,0.230813618
Marketscan,NSAID,Infection,Hospitalized infection,1293,1733,12 months,48,2.769763416
Marketscan,NSAID,Infection,Hospitalized infection,1293,1733,24 months,65,3.7507212926
Marketscan,NSAID,Infection,Hospitalized infection,1293,1733,36 months,75,4.3277553376
Marketscan,NSAID,Infection,Hospitalized infection,1293,1733,AS cohort entry to exposure,59,3.4045008656
Marketscan,NSAID,Infection,Opportunistic infection,1293,1733,12 months,14,0.807847663
Marketscan,NSAID,Infection,Opportunistic infection,1293,1733,24 months,20,1.15406809
Marketscan,NSAID,Infection,Opportunistic infection,1293,1733,36 months,24,1.384881708
Marketscan,NSAID,Infection,Opportunistic infection,1293,1733,AS cohort entry to exposure,14,0.807847663
Marketscan,NSAID,Inflammatory bowel disease,Crohn’s Disease,1293,1733,12 months,41,2.3658395845
Marketscan,NSAID,Inflammatory bowel disease,Crohn’s Disease,1293,1733,24 months,48,2.769763416
Marketscan,NSAID,Inflammatory bowel disease,Crohn’s Disease,1293,1733,36 months,53,3.0582804385
Marketscan,NSAID,Inflammatory bowel disease,Crohn’s Disease,1293,1733,AS cohort entry to exposure,44,2.538949798
Marketscan,NSAID,Inflammatory bowel disease,Ulcerative Colitis,1293,1733,12 months,26,1.500288517
Marketscan,NSAID,Inflammatory bowel disease,Ulcerative Colitis,1293,1733,24 months,29,1.6733987305
Marketscan,NSAID,Inflammatory bowel disease,Ulcerative Colitis,1293,1733,36 months,33,1.9042123485
Marketscan,NSAID,Inflammatory bowel disease,Ulcerative Colitis,1293,1733,AS cohort entry to exposure,19,1.0963646855
Marketscan,NSAID,Kidney disease,IgA nephropathy,1293,1733,12 months,0,0
Marketscan,NSAID,Kidney disease,IgA nephropathy,1293,1733,24 months,0,0
Marketscan,NSAID,Kidney disease,IgA nephropathy,1293,1733,36 months,1,0.0577034045
Marketscan,NSAID,Kidney disease,IgA nephropathy,1293,1733,AS cohort entry to exposure,0,0
Marketscan,NSAID,Kidney disease,Nephrotic syndrome,1293,1733,12 months,0,0
Marketscan,NSAID,Kidney disease,Nephrotic syndrome,1293,1733,24 months,1,0.0577034045
Marketscan,NSAID,Kidney disease,Nephrotic syndrome,1293,1733,36 months,1,0.0577034045
Marketscan,NSAID,Kidney disease,Nephrotic syndrome,1293,1733,AS cohort entry to exposure,0,0
Marketscan,NSAID,Lung disease,Interstitial lung disease,1293,1733,12 months,1,0.0577034045
Marketscan,NSAID,Lung disease,Interstitial lung disease,1293,1733,24 months,2,0.115406809
Marketscan,NSAID,Lung disease,Interstitial lung disease,1293,1733,36 months,2,0.115406809
Marketscan,NSAID,Lung disease,Interstitial lung disease,1293,1733,AS cohort entry to exposure,2,0.115406809
Marketscan,NSAID,Lung disease,Restrictive lung disease ,1293,1733,12 months,10,0.577034045
Marketscan,NSAID,Lung disease,Restrictive lung disease ,1293,1733,24 months,13,0.7501442585
Marketscan,NSAID,Lung disease,Restrictive lung disease ,1293,1733,36 months,16,0.923254472
Marketscan,NSAID,Lung disease,Restrictive lung disease ,1293,1733,AS cohort entry to exposure,13,0.7501442585
Marketscan,NSAID,Neurological Disease,Spinal Cord compression,1293,1733,12 months,7,0.4039238315
Marketscan,NSAID,Neurological Disease,Spinal Cord compression,1293,1733,24 months,13,0.7501442585
Marketscan,NSAID,Neurological Disease,Spinal Cord compression,1293,1733,36 months,14,0.807847663
Marketscan,NSAID,Neurological Disease,Spinal Cord compression,1293,1733,AS cohort entry to exposure,2,0.115406809
Marketscan,NSAID,Osteoporotic fracture,Clinical vertebral fracture,1293,1733,12 months,18,1.038661281
Marketscan,NSAID,Osteoporotic fracture,Clinical vertebral fracture,1293,1733,24 months,21,1.2117714945
Marketscan,NSAID,Osteoporotic fracture,Clinical vertebral fracture,1293,1733,36 months,24,1.384881708
Marketscan,NSAID,Osteoporotic fracture,Clinical vertebral fracture,1293,1733,AS cohort entry to exposure,9,0.5193306405
Marketscan,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1293,1733,12 months,24,1.384881708
Marketscan,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1293,1733,24 months,31,1.7888055395
Marketscan,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1293,1733,36 months,36,2.077322562
Marketscan,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1293,1733,AS cohort entry to exposure,26,1.500288517
Marketscan,NSAID,PsO/PsA,Psoriasis,1293,1733,12 months,42,2.423542989
Marketscan,NSAID,PsO/PsA,Psoriasis,1293,1733,24 months,55,3.1736872475
Marketscan,NSAID,PsO/PsA,Psoriasis,1293,1733,36 months,63,3.6353144836
Marketscan,NSAID,PsO/PsA,Psoriasis,1293,1733,AS cohort entry to exposure,40,2.30813618
Marketscan,NSAID,PsO/PsA,Psoriatic arthritis,1293,1733,12 months,38,2.192729371
Marketscan,NSAID,PsO/PsA,Psoriatic arthritis,1293,1733,24 months,41,2.3658395845
Marketscan,NSAID,PsO/PsA,Psoriatic arthritis,1293,1733,36 months,44,2.538949798
Marketscan,NSAID,PsO/PsA,Psoriatic arthritis,1293,1733,AS cohort entry to exposure,48,2.769763416
Marketscan,NSAID,Uveitis,Uveitis,1293,1733,12 months,124,7.1552221581
Marketscan,NSAID,Uveitis,Uveitis,1293,1733,24 months,159,9.1748413156
Marketscan,NSAID,Uveitis,Uveitis,1293,1733,36 months,165,9.5210617426
Marketscan,NSAID,Uveitis,Uveitis,1293,1733,AS cohort entry to exposure,130,7.5014425851
Marketscan,No exposure,Cancer,Hematologic Cancer,1699,1699,12 months,8,0.4708652148
Marketscan,No exposure,Cancer,Hematologic Cancer,1699,1699,24 months,9,0.5297233667
Marketscan,No exposure,Cancer,Hematologic Cancer,1699,1699,36 months,11,0.6474396704
Marketscan,No exposure,Cancer,Hematologic Cancer,1699,1699,AS cohort entry to exposure,0,0
Marketscan,No exposure,Cancer,Non Melanoma Skin Cancer,1699,1699,12 months,15,0.8828722778
Marketscan,No exposure,Cancer,Non Melanoma Skin Cancer,1699,1699,24 months,20,1.1771630371
Marketscan,No exposure,Cancer,Non Melanoma Skin Cancer,1699,1699,36 months,22,1.2948793408
Marketscan,No exposure,Cancer,Non Melanoma Skin Cancer,1699,1699,AS cohort entry to exposure,1,0.0588581519
Marketscan,No exposure,Cancer,Solid Cancer,1699,1699,12 months,45,2.6486168334
Marketscan,No exposure,Cancer,Solid Cancer,1699,1699,24 months,60,3.5314891112
Marketscan,No exposure,Cancer,Solid Cancer,1699,1699,36 months,66,3.8846380224
Marketscan,No exposure,Cancer,Solid Cancer,1699,1699,AS cohort entry to exposure,1,0.0588581519
Marketscan,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1699,1699,12 months,23,1.3537374926
Marketscan,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1699,1699,24 months,28,1.6480282519
Marketscan,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1699,1699,36 months,30,1.7657445556
Marketscan,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1699,1699,AS cohort entry to exposure,3,0.1765744556
Marketscan,No exposure,Cardiac disease,Conduction Block,1699,1699,12 months,23,1.3537374926
Marketscan,No exposure,Cardiac disease,Conduction Block,1699,1699,24 months,32,1.8834608593
Marketscan,No exposure,Cardiac disease,Conduction Block,1699,1699,36 months,36,2.1188934667
Marketscan,No exposure,Cardiac disease,Conduction Block,1699,1699,AS cohort entry to exposure,0,0
Marketscan,No exposure,Cardiac disease,Myocardial infarction,1699,1699,12 months,1,0.0588581519
Marketscan,No exposure,Cardiac disease,Myocardial infarction,1699,1699,24 months,5,0.2942907593
Marketscan,No exposure,Cardiac disease,Myocardial infarction,1699,1699,36 months,6,0.3531489111
Marketscan,No exposure,Cardiac disease,Myocardial infarction,1699,1699,AS cohort entry to exposure,0,0
Marketscan,No exposure,Infection,Hospitalized infection,1699,1699,12 months,36,2.1188934667
Marketscan,No exposure,Infection,Hospitalized infection,1699,1699,24 months,62,3.6492054149
Marketscan,No exposure,Infection,Hospitalized infection,1699,1699,36 months,74,4.3555032372
Marketscan,No exposure,Infection,Hospitalized infection,1699,1699,AS cohort entry to exposure,0,0
Marketscan,No exposure,Infection,Opportunistic infection,1699,1699,12 months,10,0.5885815185
Marketscan,No exposure,Infection,Opportunistic infection,1699,1699,24 months,14,0.824014126
Marketscan,No exposure,Infection,Opportunistic infection,1699,1699,36 months,17,1.0005885815
Marketscan,No exposure,Infection,Opportunistic infection,1699,1699,AS cohort entry to exposure,0,0
Marketscan,No exposure,Inflammatory bowel disease,Crohn’s Disease,1699,1699,12 months,52,3.0606238964
Marketscan,No exposure,Inflammatory bowel disease,Crohn’s Disease,1699,1699,24 months,68,4.0023543261
Marketscan,No exposure,Inflammatory bowel disease,Crohn’s Disease,1699,1699,36 months,74,4.3555032372
Marketscan,No exposure,Inflammatory bowel disease,Crohn’s Disease,1699,1699,AS cohort entry to exposure,13,0.7651559741
Marketscan,No exposure,Inflammatory bowel disease,Ulcerative Colitis,1699,1699,12 months,43,2.5309005297
Marketscan,No exposure,Inflammatory bowel disease,Ulcerative Colitis,1699,1699,24 months,56,3.2960565038
Marketscan,No exposure,Inflammatory bowel disease,Ulcerative Colitis,1699,1699,36 months,58,3.4137728075
Marketscan,No exposure,Inflammatory bowel disease,Ulcerative Colitis,1699,1699,AS cohort entry to exposure,7,0.412007063
Marketscan,No exposure,Kidney disease,Amyloidosis,1699,1699,12 months,1,0.0588581519
Marketscan,No exposure,Kidney disease,Amyloidosis,1699,1699,24 months,1,0.0588581519
Marketscan,No exposure,Kidney disease,Amyloidosis,1699,1699,36 months,1,0.0588581519
Marketscan,No exposure,Kidney disease,Amyloidosis,1699,1699,AS cohort entry to exposure,0,0
Marketscan,No exposure,Kidney disease,IgA nephropathy,1699,1699,12 months,3,0.1765744556
Marketscan,No exposure,Kidney disease,IgA nephropathy,1699,1699,24 months,4,0.2354326074
Marketscan,No exposure,Kidney disease,IgA nephropathy,1699,1699,36 months,4,0.2354326074
Marketscan,No exposure,Kidney disease,IgA nephropathy,1699,1699,AS cohort entry to exposure,0,0
Marketscan,No exposure,Kidney disease,Nephrotic syndrome,1699,1699,12 months,2,0.1177163037
Marketscan,No exposure,Kidney disease,Nephrotic syndrome,1699,1699,24 months,2,0.1177163037
Marketscan,No exposure,Kidney disease,Nephrotic syndrome,1699,1699,36 months,2,0.1177163037
Marketscan,No exposure,Kidney disease,Nephrotic syndrome,1699,1699,AS cohort entry to exposure,0,0
Marketscan,No exposure,Lung disease,Interstitial lung disease,1699,1699,12 months,0,0
Marketscan,No exposure,Lung disease,Interstitial lung disease,1699,1699,24 months,0,0
Marketscan,No exposure,Lung disease,Interstitial lung disease,1699,1699,36 months,1,0.0588581519
Marketscan,No exposure,Lung disease,Interstitial lung disease,1699,1699,AS cohort entry to exposure,0,0
Marketscan,No exposure,Lung disease,Restrictive lung disease ,1699,1699,12 months,16,0.9417304297
Marketscan,No exposure,Lung disease,Restrictive lung disease ,1699,1699,24 months,23,1.3537374926
Marketscan,No exposure,Lung disease,Restrictive lung disease ,1699,1699,36 months,28,1.6480282519
Marketscan,No exposure,Lung disease,Restrictive lung disease ,1699,1699,AS cohort entry to exposure,0,0
Marketscan,No exposure,Neurological Disease,Cauda Equina syndrome,1699,1699,12 months,1,0.0588581519
Marketscan,No exposure,Neurological Disease,Cauda Equina syndrome,1699,1699,24 months,2,0.1177163037
Marketscan,No exposure,Neurological Disease,Cauda Equina syndrome,1699,1699,36 months,2,0.1177163037
Marketscan,No exposure,Neurological Disease,Cauda Equina syndrome,1699,1699,AS cohort entry to exposure,1,0.0588581519
Marketscan,No exposure,Neurological Disease,Spinal Cord compression,1699,1699,12 months,0,0
Marketscan,No exposure,Neurological Disease,Spinal Cord compression,1699,1699,24 months,3,0.1765744556
Marketscan,No exposure,Neurological Disease,Spinal Cord compression,1699,1699,36 months,4,0.2354326074
Marketscan,No exposure,Neurological Disease,Spinal Cord compression,1699,1699,AS cohort entry to exposure,0,0
Marketscan,No exposure,Osteoporotic fracture,Clinical vertebral fracture,1699,1699,12 months,14,0.824014126
Marketscan,No exposure,Osteoporotic fracture,Clinical vertebral fracture,1699,1699,24 months,23,1.3537374926
Marketscan,No exposure,Osteoporotic fracture,Clinical vertebral fracture,1699,1699,36 months,26,1.5303119482
Marketscan,No exposure,Osteoporotic fracture,Clinical vertebral fracture,1699,1699,AS cohort entry to exposure,1,0.0588581519
Marketscan,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1699,1699,12 months,19,1.1183048852
Marketscan,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1699,1699,24 months,30,1.7657445556
Marketscan,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1699,1699,36 months,36,2.1188934667
Marketscan,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1699,1699,AS cohort entry to exposure,0,0
Marketscan,No exposure,PsO/PsA,Psoriasis,1699,1699,12 months,50,2.9429075927
Marketscan,No exposure,PsO/PsA,Psoriasis,1699,1699,24 months,58,3.4137728075
Marketscan,No exposure,PsO/PsA,Psoriasis,1699,1699,36 months,61,3.5903472631
Marketscan,No exposure,PsO/PsA,Psoriasis,1699,1699,AS cohort entry to exposure,13,0.7651559741
Marketscan,No exposure,PsO/PsA,Psoriatic arthritis,1699,1699,12 months,45,2.6486168334
Marketscan,No exposure,PsO/PsA,Psoriatic arthritis,1699,1699,24 months,57,3.3549146557
Marketscan,No exposure,PsO/PsA,Psoriatic arthritis,1699,1699,36 months,62,3.6492054149
Marketscan,No exposure,PsO/PsA,Psoriatic arthritis,1699,1699,AS cohort entry to exposure,18,1.0594467334
Marketscan,No exposure,Uveitis,Uveitis,1699,1699,12 months,165,9.7115950559
Marketscan,No exposure,Uveitis,Uveitis,1699,1699,24 months,197,11.595055915
Marketscan,No exposure,Uveitis,Uveitis,1699,1699,36 months,209,12.301353737
Marketscan,No exposure,Uveitis,Uveitis,1699,1699,AS cohort entry to exposure,41,2.413184226
Marketscan,TNF,Cancer,Hematologic Cancer,2864,3453,12 months,2,0.0579206487
Marketscan,TNF,Cancer,Hematologic Cancer,2864,3453,24 months,8,0.2316825948
Marketscan,TNF,Cancer,Hematologic Cancer,2864,3453,36 months,8,0.2316825948
Marketscan,TNF,Cancer,Hematologic Cancer,2864,3453,AS cohort entry to exposure,2,0.0579206487
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,2864,3453,12 months,18,0.5212858384
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,2864,3453,24 months,40,1.1584129742
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,2864,3453,36 months,47,1.3611352447
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,2864,3453,AS cohort entry to exposure,21,0.6081668115
Marketscan,TNF,Cancer,Solid Cancer,2864,3453,12 months,71,2.0561830292
Marketscan,TNF,Cancer,Solid Cancer,2864,3453,24 months,93,2.6933101651
Marketscan,TNF,Cancer,Solid Cancer,2864,3453,36 months,100,2.8960324356
Marketscan,TNF,Cancer,Solid Cancer,2864,3453,AS cohort entry to exposure,49,1.4190558934
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2864,3453,12 months,28,0.810889082
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2864,3453,24 months,35,1.0136113524
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2864,3453,36 months,41,1.1873732986
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2864,3453,AS cohort entry to exposure,24,0.6950477845
Marketscan,TNF,Cardiac disease,Conduction Block,2864,3453,12 months,23,0.6660874602
Marketscan,TNF,Cardiac disease,Conduction Block,2864,3453,24 months,35,1.0136113524
Marketscan,TNF,Cardiac disease,Conduction Block,2864,3453,36 months,42,1.2163336229
Marketscan,TNF,Cardiac disease,Conduction Block,2864,3453,AS cohort entry to exposure,19,0.5502461628
Marketscan,TNF,Cardiac disease,Myocardial infarction,2864,3453,12 months,5,0.1448016218
Marketscan,TNF,Cardiac disease,Myocardial infarction,2864,3453,24 months,13,0.3764842166
Marketscan,TNF,Cardiac disease,Myocardial infarction,2864,3453,36 months,13,0.3764842166
Marketscan,TNF,Cardiac disease,Myocardial infarction,2864,3453,AS cohort entry to exposure,4,0.1158412974
Marketscan,TNF,Infection,Hospitalized infection,2864,3453,12 months,104,3.011873733
Marketscan,TNF,Infection,Hospitalized infection,2864,3453,24 months,156,4.5178105995
Marketscan,TNF,Infection,Hospitalized infection,2864,3453,36 months,176,5.0970170866
Marketscan,TNF,Infection,Hospitalized infection,2864,3453,AS cohort entry to exposure,79,2.2878656241
Marketscan,TNF,Infection,Opportunistic infection,2864,3453,12 months,38,1.1004923255
Marketscan,TNF,Infection,Opportunistic infection,2864,3453,24 months,51,1.4769765421
Marketscan,TNF,Infection,Opportunistic infection,2864,3453,36 months,57,1.6507384883
Marketscan,TNF,Infection,Opportunistic infection,2864,3453,AS cohort entry to exposure,29,0.8398494063
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,2864,3453,12 months,171,4.9522154648
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,2864,3453,24 months,194,5.618302925
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,2864,3453,36 months,201,5.8210251955
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,2864,3453,AS cohort entry to exposure,138,3.9965247611
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,2864,3453,12 months,102,2.9539530843
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,2864,3453,24 months,122,3.5331595714
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,2864,3453,36 months,132,3.8227628149
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,2864,3453,AS cohort entry to exposure,66,1.9113814075
Marketscan,TNF,Kidney disease,Amyloidosis,2864,3453,12 months,1,0.0289603244
Marketscan,TNF,Kidney disease,Amyloidosis,2864,3453,24 months,2,0.0579206487
Marketscan,TNF,Kidney disease,Amyloidosis,2864,3453,36 months,2,0.0579206487
Marketscan,TNF,Kidney disease,Amyloidosis,2864,3453,AS cohort entry to exposure,0,0
Marketscan,TNF,Kidney disease,IgA nephropathy,2864,3453,12 months,5,0.1448016218
Marketscan,TNF,Kidney disease,IgA nephropathy,2864,3453,24 months,7,0.2027222705
Marketscan,TNF,Kidney disease,IgA nephropathy,2864,3453,36 months,7,0.2027222705
Marketscan,TNF,Kidney disease,IgA nephropathy,2864,3453,AS cohort entry to exposure,5,0.1448016218
Marketscan,TNF,Kidney disease,Nephrotic syndrome,2864,3453,12 months,3,0.0868809731
Marketscan,TNF,Kidney disease,Nephrotic syndrome,2864,3453,24 months,5,0.1448016218
Marketscan,TNF,Kidney disease,Nephrotic syndrome,2864,3453,36 months,5,0.1448016218
Marketscan,TNF,Kidney disease,Nephrotic syndrome,2864,3453,AS cohort entry to exposure,2,0.0579206487
Marketscan,TNF,Lung disease,Interstitial lung disease,2864,3453,12 months,5,0.1448016218
Marketscan,TNF,Lung disease,Interstitial lung disease,2864,3453,24 months,5,0.1448016218
Marketscan,TNF,Lung disease,Interstitial lung disease,2864,3453,36 months,5,0.1448016218
Marketscan,TNF,Lung disease,Interstitial lung disease,2864,3453,AS cohort entry to exposure,3,0.0868809731
Marketscan,TNF,Lung disease,Restrictive lung disease ,2864,3453,12 months,26,0.7529684332
Marketscan,TNF,Lung disease,Restrictive lung disease ,2864,3453,24 months,37,1.0715320012
Marketscan,TNF,Lung disease,Restrictive lung disease ,2864,3453,36 months,41,1.1873732986
Marketscan,TNF,Lung disease,Restrictive lung disease ,2864,3453,AS cohort entry to exposure,20,0.5792064871
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,2864,3453,12 months,0,0
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,2864,3453,24 months,1,0.0289603244
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,2864,3453,36 months,1,0.0289603244
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,2864,3453,AS cohort entry to exposure,0,0
Marketscan,TNF,Neurological Disease,Spinal Cord compression,2864,3453,12 months,6,0.1737619461
Marketscan,TNF,Neurological Disease,Spinal Cord compression,2864,3453,24 months,11,0.3185635679
Marketscan,TNF,Neurological Disease,Spinal Cord compression,2864,3453,36 months,16,0.4633651897
Marketscan,TNF,Neurological Disease,Spinal Cord compression,2864,3453,AS cohort entry to exposure,2,0.0579206487
Marketscan,TNF,Osteoporotic fracture,Clinical vertebral fracture,2864,3453,12 months,14,0.405444541
Marketscan,TNF,Osteoporotic fracture,Clinical vertebral fracture,2864,3453,24 months,23,0.6660874602
Marketscan,TNF,Osteoporotic fracture,Clinical vertebral fracture,2864,3453,36 months,24,0.6950477845
Marketscan,TNF,Osteoporotic fracture,Clinical vertebral fracture,2864,3453,AS cohort entry to exposure,7,0.2027222705
Marketscan,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2864,3453,12 months,26,0.7529684332
Marketscan,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2864,3453,24 months,58,1.6796988126
Marketscan,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2864,3453,36 months,67,1.9403417318
Marketscan,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2864,3453,AS cohort entry to exposure,22,0.6371271358
Marketscan,TNF,PsO/PsA,Psoriasis,2864,3453,12 months,129,3.7358818419
Marketscan,TNF,PsO/PsA,Psoriasis,2864,3453,24 months,168,4.8653344917
Marketscan,TNF,PsO/PsA,Psoriasis,2864,3453,36 months,194,5.618302925
Marketscan,TNF,PsO/PsA,Psoriasis,2864,3453,AS cohort entry to exposure,90,2.606429192
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,2864,3453,12 months,202,5.8499855198
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,2864,3453,24 months,242,7.0083984941
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,2864,3453,36 months,255,7.3848827107
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,2864,3453,AS cohort entry to exposure,163,4.72053287
Marketscan,TNF,Uveitis,Uveitis,2864,3453,12 months,259,7.5007240081
Marketscan,TNF,Uveitis,Uveitis,2864,3453,24 months,311,9.0066608746
Marketscan,TNF,Uveitis,Uveitis,2864,3453,36 months,339,9.8175499566
Marketscan,TNF,Uveitis,Uveitis,2864,3453,AS cohort entry to exposure,210,6.0816681147
Medicare,DMARD,Cancer,Hematologic Cancer,550,642,12 months,15,2.3364485981
Medicare,DMARD,Cancer,Hematologic Cancer,550,642,24 months,18,2.8037383178
Medicare,DMARD,Cancer,Hematologic Cancer,550,642,36 months,18,2.8037383178
Medicare,DMARD,Cancer,Hematologic Cancer,550,642,AS cohort entry to exposure,12,1.8691588785
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,550,642,12 months,15,2.3364485981
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,550,642,24 months,27,4.2056074766
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,550,642,36 months,40,6.230529595
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,550,642,AS cohort entry to exposure,14,2.1806853583
Medicare,DMARD,Cancer,Solid Cancer,550,642,12 months,89,13.862928349
Medicare,DMARD,Cancer,Solid Cancer,550,642,24 months,114,17.757009346
Medicare,DMARD,Cancer,Solid Cancer,550,642,36 months,129,20.093457944
Medicare,DMARD,Cancer,Solid Cancer,550,642,AS cohort entry to exposure,76,11.838006231
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,550,642,12 months,31,4.8286604361
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,550,642,24 months,53,8.2554517134
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,550,642,36 months,60,9.3457943925
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,550,642,AS cohort entry to exposure,32,4.984423676
Medicare,DMARD,Cardiac disease,Conduction Block,550,642,12 months,32,4.984423676
Medicare,DMARD,Cardiac disease,Conduction Block,550,642,24 months,46,7.1651090343
Medicare,DMARD,Cardiac disease,Conduction Block,550,642,36 months,57,8.8785046729
Medicare,DMARD,Cardiac disease,Conduction Block,550,642,AS cohort entry to exposure,25,3.8940809969
Medicare,DMARD,Cardiac disease,Myocardial infarction,550,642,12 months,8,1.246105919
Medicare,DMARD,Cardiac disease,Myocardial infarction,550,642,24 months,13,2.0249221184
Medicare,DMARD,Cardiac disease,Myocardial infarction,550,642,36 months,16,2.492211838
Medicare,DMARD,Cardiac disease,Myocardial infarction,550,642,AS cohort entry to exposure,8,1.246105919
Medicare,DMARD,Infection,Hospitalized infection,550,642,12 months,76,11.838006231
Medicare,DMARD,Infection,Hospitalized infection,550,642,24 months,117,18.224299065
Medicare,DMARD,Infection,Hospitalized infection,550,642,36 months,143,22.274143302
Medicare,DMARD,Infection,Hospitalized infection,550,642,AS cohort entry to exposure,91,14.174454829
Medicare,DMARD,Infection,Opportunistic infection,550,642,12 months,14,2.1806853583
Medicare,DMARD,Infection,Opportunistic infection,550,642,24 months,24,3.738317757
Medicare,DMARD,Infection,Opportunistic infection,550,642,36 months,27,4.2056074766
Medicare,DMARD,Infection,Opportunistic infection,550,642,AS cohort entry to exposure,24,3.738317757
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,550,642,12 months,21,3.2710280374
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,550,642,24 months,24,3.738317757
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,550,642,36 months,25,3.8940809969
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,550,642,AS cohort entry to exposure,19,2.9595015576
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,550,642,12 months,24,3.738317757
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,550,642,24 months,33,5.1401869159
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,550,642,36 months,33,5.1401869159
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,550,642,AS cohort entry to exposure,23,3.5825545171
Medicare,DMARD,Kidney disease,Amyloidosis,550,642,12 months,2,0.3115264798
Medicare,DMARD,Kidney disease,Amyloidosis,550,642,24 months,2,0.3115264798
Medicare,DMARD,Kidney disease,Amyloidosis,550,642,36 months,2,0.3115264798
Medicare,DMARD,Kidney disease,Amyloidosis,550,642,AS cohort entry to exposure,2,0.3115264798
Medicare,DMARD,Kidney disease,IgA nephropathy,550,642,12 months,0,0
Medicare,DMARD,Kidney disease,IgA nephropathy,550,642,24 months,1,0.1557632399
Medicare,DMARD,Kidney disease,IgA nephropathy,550,642,36 months,1,0.1557632399
Medicare,DMARD,Kidney disease,IgA nephropathy,550,642,AS cohort entry to exposure,3,0.4672897196
Medicare,DMARD,Kidney disease,Nephrotic syndrome,550,642,12 months,4,0.6230529595
Medicare,DMARD,Kidney disease,Nephrotic syndrome,550,642,24 months,5,0.7788161994
Medicare,DMARD,Kidney disease,Nephrotic syndrome,550,642,36 months,5,0.7788161994
Medicare,DMARD,Kidney disease,Nephrotic syndrome,550,642,AS cohort entry to exposure,2,0.3115264798
Medicare,DMARD,Lung disease,Interstitial lung disease,550,642,12 months,3,0.4672897196
Medicare,DMARD,Lung disease,Interstitial lung disease,550,642,24 months,8,1.246105919
Medicare,DMARD,Lung disease,Interstitial lung disease,550,642,36 months,12,1.8691588785
Medicare,DMARD,Lung disease,Interstitial lung disease,550,642,AS cohort entry to exposure,6,0.9345794393
Medicare,DMARD,Lung disease,Restrictive lung disease ,550,642,12 months,27,4.2056074766
Medicare,DMARD,Lung disease,Restrictive lung disease ,550,642,24 months,35,5.4517133956
Medicare,DMARD,Lung disease,Restrictive lung disease ,550,642,36 months,47,7.3208722741
Medicare,DMARD,Lung disease,Restrictive lung disease ,550,642,AS cohort entry to exposure,27,4.2056074766
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,550,642,12 months,0,0
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,550,642,24 months,0,0
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,550,642,36 months,1,0.1557632399
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,550,642,AS cohort entry to exposure,0,0
Medicare,DMARD,Neurological Disease,Spinal Cord compression,550,642,12 months,2,0.3115264798
Medicare,DMARD,Neurological Disease,Spinal Cord compression,550,642,24 months,4,0.6230529595
Medicare,DMARD,Neurological Disease,Spinal Cord compression,550,642,36 months,4,0.6230529595
Medicare,DMARD,Neurological Disease,Spinal Cord compression,550,642,AS cohort entry to exposure,1,0.1557632399
Medicare,DMARD,Osteoporotic fracture,Clinical vertebral fracture,550,642,12 months,18,2.8037383178
Medicare,DMARD,Osteoporotic fracture,Clinical vertebral fracture,550,642,24 months,29,4.5171339564
Medicare,DMARD,Osteoporotic fracture,Clinical vertebral fracture,550,642,36 months,39,6.0747663551
Medicare,DMARD,Osteoporotic fracture,Clinical vertebral fracture,550,642,AS cohort entry to exposure,20,3.1152647975
Medicare,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,550,642,12 months,21,3.2710280374
Medicare,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,550,642,24 months,42,6.5420560748
Medicare,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,550,642,36 months,50,7.7881619938
Medicare,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,550,642,AS cohort entry to exposure,35,5.4517133956
Medicare,DMARD,PsO/PsA,Psoriasis,550,642,12 months,21,3.2710280374
Medicare,DMARD,PsO/PsA,Psoriasis,550,642,24 months,26,4.0498442368
Medicare,DMARD,PsO/PsA,Psoriasis,550,642,36 months,31,4.8286604361
Medicare,DMARD,PsO/PsA,Psoriasis,550,642,AS cohort entry to exposure,24,3.738317757
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,550,642,12 months,40,6.230529595
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,550,642,24 months,47,7.3208722741
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,550,642,36 months,53,8.2554517134
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,550,642,AS cohort entry to exposure,45,7.0093457944
Medicare,DMARD,Uveitis,Uveitis,550,642,12 months,34,5.2959501558
Medicare,DMARD,Uveitis,Uveitis,550,642,24 months,39,6.0747663551
Medicare,DMARD,Uveitis,Uveitis,550,642,36 months,44,6.8535825545
Medicare,DMARD,Uveitis,Uveitis,550,642,AS cohort entry to exposure,33,5.1401869159
Medicare,NSAID,Cancer,Hematologic Cancer,1108,1629,12 months,43,2.6396562308
Medicare,NSAID,Cancer,Hematologic Cancer,1108,1629,24 months,46,2.8238182934
Medicare,NSAID,Cancer,Hematologic Cancer,1108,1629,36 months,50,3.0693677103
Medicare,NSAID,Cancer,Hematologic Cancer,1108,1629,AS cohort entry to exposure,52,3.1921424187
Medicare,NSAID,Cancer,Non Melanoma Skin Cancer,1108,1629,12 months,52,3.1921424187
Medicare,NSAID,Cancer,Non Melanoma Skin Cancer,1108,1629,24 months,82,5.0337630448
Medicare,NSAID,Cancer,Non Melanoma Skin Cancer,1108,1629,36 months,110,6.7526089626
Medicare,NSAID,Cancer,Non Melanoma Skin Cancer,1108,1629,AS cohort entry to exposure,59,3.6218538981
Medicare,NSAID,Cancer,Solid Cancer,1108,1629,12 months,251,15.408225905
Medicare,NSAID,Cancer,Solid Cancer,1108,1629,24 months,308,18.907305095
Medicare,NSAID,Cancer,Solid Cancer,1108,1629,36 months,345,21.178637201
Medicare,NSAID,Cancer,Solid Cancer,1108,1629,AS cohort entry to exposure,275,16.881522406
Medicare,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1108,1629,12 months,122,7.489257213
Medicare,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1108,1629,24 months,165,10.128913444
Medicare,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1108,1629,36 months,194,11.909146716
Medicare,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1108,1629,AS cohort entry to exposure,150,9.2081031308
Medicare,NSAID,Cardiac disease,Conduction Block,1108,1629,12 months,80,4.9109883364
Medicare,NSAID,Cardiac disease,Conduction Block,1108,1629,24 months,109,6.6912216083
Medicare,NSAID,Cardiac disease,Conduction Block,1108,1629,36 months,129,7.9189686924
Medicare,NSAID,Cardiac disease,Conduction Block,1108,1629,AS cohort entry to exposure,124,7.6120319214
Medicare,NSAID,Cardiac disease,Myocardial infarction,1108,1629,12 months,20,1.2277470841
Medicare,NSAID,Cardiac disease,Myocardial infarction,1108,1629,24 months,29,1.7802332719
Medicare,NSAID,Cardiac disease,Myocardial infarction,1108,1629,36 months,40,2.4554941682
Medicare,NSAID,Cardiac disease,Myocardial infarction,1108,1629,AS cohort entry to exposure,36,2.2099447514
Medicare,NSAID,Infection,Hospitalized infection,1108,1629,12 months,199,12.216083487
Medicare,NSAID,Infection,Hospitalized infection,1108,1629,24 months,299,18.354818907
Medicare,NSAID,Infection,Hospitalized infection,1108,1629,36 months,369,22.651933702
Medicare,NSAID,Infection,Hospitalized infection,1108,1629,AS cohort entry to exposure,310,19.030079804
Medicare,NSAID,Infection,Opportunistic infection,1108,1629,12 months,32,1.9643953346
Medicare,NSAID,Infection,Opportunistic infection,1108,1629,24 months,56,3.4376918355
Medicare,NSAID,Infection,Opportunistic infection,1108,1629,36 months,78,4.788213628
Medicare,NSAID,Infection,Opportunistic infection,1108,1629,AS cohort entry to exposure,58,3.5604665439
Medicare,NSAID,Inflammatory bowel disease,Crohn’s Disease,1108,1629,12 months,21,1.2891344383
Medicare,NSAID,Inflammatory bowel disease,Crohn’s Disease,1108,1629,24 months,29,1.7802332719
Medicare,NSAID,Inflammatory bowel disease,Crohn’s Disease,1108,1629,36 months,31,1.9030079804
Medicare,NSAID,Inflammatory bowel disease,Crohn’s Disease,1108,1629,AS cohort entry to exposure,36,2.2099447514
Medicare,NSAID,Inflammatory bowel disease,Ulcerative Colitis,1108,1629,12 months,21,1.2891344383
Medicare,NSAID,Inflammatory bowel disease,Ulcerative Colitis,1108,1629,24 months,27,1.6574585635
Medicare,NSAID,Inflammatory bowel disease,Ulcerative Colitis,1108,1629,36 months,34,2.087170043
Medicare,NSAID,Inflammatory bowel disease,Ulcerative Colitis,1108,1629,AS cohort entry to exposure,36,2.2099447514
Medicare,NSAID,Kidney disease,Amyloidosis,1108,1629,12 months,1,0.0613873542
Medicare,NSAID,Kidney disease,Amyloidosis,1108,1629,24 months,1,0.0613873542
Medicare,NSAID,Kidney disease,Amyloidosis,1108,1629,36 months,1,0.0613873542
Medicare,NSAID,Kidney disease,Amyloidosis,1108,1629,AS cohort entry to exposure,2,0.1227747084
Medicare,NSAID,Kidney disease,IgA nephropathy,1108,1629,12 months,1,0.0613873542
Medicare,NSAID,Kidney disease,IgA nephropathy,1108,1629,24 months,1,0.0613873542
Medicare,NSAID,Kidney disease,IgA nephropathy,1108,1629,36 months,2,0.1227747084
Medicare,NSAID,Kidney disease,IgA nephropathy,1108,1629,AS cohort entry to exposure,4,0.2455494168
Medicare,NSAID,Kidney disease,Nephrotic syndrome,1108,1629,12 months,3,0.1841620626
Medicare,NSAID,Kidney disease,Nephrotic syndrome,1108,1629,24 months,3,0.1841620626
Medicare,NSAID,Kidney disease,Nephrotic syndrome,1108,1629,36 months,3,0.1841620626
Medicare,NSAID,Kidney disease,Nephrotic syndrome,1108,1629,AS cohort entry to exposure,3,0.1841620626
Medicare,NSAID,Lung disease,Interstitial lung disease,1108,1629,12 months,4,0.2455494168
Medicare,NSAID,Lung disease,Interstitial lung disease,1108,1629,24 months,6,0.3683241252
Medicare,NSAID,Lung disease,Interstitial lung disease,1108,1629,36 months,10,0.6138735421
Medicare,NSAID,Lung disease,Interstitial lung disease,1108,1629,AS cohort entry to exposure,11,0.6752608963
Medicare,NSAID,Lung disease,Restrictive lung disease ,1108,1629,12 months,60,3.6832412523
Medicare,NSAID,Lung disease,Restrictive lung disease ,1108,1629,24 months,91,5.5862492327
Medicare,NSAID,Lung disease,Restrictive lung disease ,1108,1629,36 months,112,6.875383671
Medicare,NSAID,Lung disease,Restrictive lung disease ,1108,1629,AS cohort entry to exposure,100,6.1387354205
Medicare,NSAID,Neurological Disease,Cauda Equina syndrome,1108,1629,12 months,2,0.1227747084
Medicare,NSAID,Neurological Disease,Cauda Equina syndrome,1108,1629,24 months,2,0.1227747084
Medicare,NSAID,Neurological Disease,Cauda Equina syndrome,1108,1629,36 months,3,0.1841620626
Medicare,NSAID,Neurological Disease,Cauda Equina syndrome,1108,1629,AS cohort entry to exposure,5,0.306936771
Medicare,NSAID,Neurological Disease,Spinal Cord compression,1108,1629,12 months,5,0.306936771
Medicare,NSAID,Neurological Disease,Spinal Cord compression,1108,1629,24 months,7,0.4297114794
Medicare,NSAID,Neurological Disease,Spinal Cord compression,1108,1629,36 months,10,0.6138735421
Medicare,NSAID,Neurological Disease,Spinal Cord compression,1108,1629,AS cohort entry to exposure,5,0.306936771
Medicare,NSAID,Osteoporotic fracture,Clinical vertebral fracture,1108,1629,12 months,75,4.6040515654
Medicare,NSAID,Osteoporotic fracture,Clinical vertebral fracture,1108,1629,24 months,107,6.5684468999
Medicare,NSAID,Osteoporotic fracture,Clinical vertebral fracture,1108,1629,36 months,119,7.3050951504
Medicare,NSAID,Osteoporotic fracture,Clinical vertebral fracture,1108,1629,AS cohort entry to exposure,93,5.7090239411
Medicare,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1108,1629,12 months,69,4.2357274401
Medicare,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1108,1629,24 months,102,6.2615101289
Medicare,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1108,1629,36 months,131,8.0417434009
Medicare,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1108,1629,AS cohort entry to exposure,133,8.1645181093
Medicare,NSAID,PsO/PsA,Psoriasis,1108,1629,12 months,36,2.2099447514
Medicare,NSAID,PsO/PsA,Psoriasis,1108,1629,24 months,51,3.1307550645
Medicare,NSAID,PsO/PsA,Psoriasis,1108,1629,36 months,64,3.9287906691
Medicare,NSAID,PsO/PsA,Psoriasis,1108,1629,AS cohort entry to exposure,61,3.7446286065
Medicare,NSAID,PsO/PsA,Psoriatic arthritis,1108,1629,12 months,41,2.5168815224
Medicare,NSAID,PsO/PsA,Psoriatic arthritis,1108,1629,24 months,55,3.3763044813
Medicare,NSAID,PsO/PsA,Psoriatic arthritis,1108,1629,36 months,59,3.6218538981
Medicare,NSAID,PsO/PsA,Psoriatic arthritis,1108,1629,AS cohort entry to exposure,59,3.6218538981
Medicare,NSAID,Uveitis,Uveitis,1108,1629,12 months,68,4.1743400859
Medicare,NSAID,Uveitis,Uveitis,1108,1629,24 months,86,5.2793124616
Medicare,NSAID,Uveitis,Uveitis,1108,1629,36 months,96,5.8931860037
Medicare,NSAID,Uveitis,Uveitis,1108,1629,AS cohort entry to exposure,98,6.0159607121
Medicare,No exposure,Cancer,Hematologic Cancer,1244,1244,12 months,14,1.1254019293
Medicare,No exposure,Cancer,Hematologic Cancer,1244,1244,24 months,21,1.6881028939
Medicare,No exposure,Cancer,Hematologic Cancer,1244,1244,36 months,25,2.0096463023
Medicare,No exposure,Cancer,Hematologic Cancer,1244,1244,AS cohort entry to exposure,2,0.1607717042
Medicare,No exposure,Cancer,Non Melanoma Skin Cancer,1244,1244,12 months,27,2.1704180064
Medicare,No exposure,Cancer,Non Melanoma Skin Cancer,1244,1244,24 months,39,3.1350482315
Medicare,No exposure,Cancer,Non Melanoma Skin Cancer,1244,1244,36 months,53,4.2604501608
Medicare,No exposure,Cancer,Non Melanoma Skin Cancer,1244,1244,AS cohort entry to exposure,0,0
Medicare,No exposure,Cancer,Solid Cancer,1244,1244,12 months,200,16.077170418
Medicare,No exposure,Cancer,Solid Cancer,1244,1244,24 months,232,18.649517685
Medicare,No exposure,Cancer,Solid Cancer,1244,1244,36 months,263,21.1414791
Medicare,No exposure,Cancer,Solid Cancer,1244,1244,AS cohort entry to exposure,14,1.1254019293
Medicare,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1244,1244,12 months,91,7.3151125402
Medicare,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1244,1244,24 months,120,9.6463022508
Medicare,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1244,1244,36 months,139,11.173633441
Medicare,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1244,1244,AS cohort entry to exposure,3,0.2411575563
Medicare,No exposure,Cardiac disease,Conduction Block,1244,1244,12 months,60,4.8231511254
Medicare,No exposure,Cardiac disease,Conduction Block,1244,1244,24 months,94,7.5562700965
Medicare,No exposure,Cardiac disease,Conduction Block,1244,1244,36 months,116,9.3247588424
Medicare,No exposure,Cardiac disease,Conduction Block,1244,1244,AS cohort entry to exposure,0,0
Medicare,No exposure,Cardiac disease,Myocardial infarction,1244,1244,12 months,16,1.2861736334
Medicare,No exposure,Cardiac disease,Myocardial infarction,1244,1244,24 months,31,2.4919614148
Medicare,No exposure,Cardiac disease,Myocardial infarction,1244,1244,36 months,42,3.3762057878
Medicare,No exposure,Cardiac disease,Myocardial infarction,1244,1244,AS cohort entry to exposure,0,0
Medicare,No exposure,Infection,Hospitalized infection,1244,1244,12 months,111,8.922829582
Medicare,No exposure,Infection,Hospitalized infection,1244,1244,24 months,200,16.077170418
Medicare,No exposure,Infection,Hospitalized infection,1244,1244,36 months,266,21.382636656
Medicare,No exposure,Infection,Hospitalized infection,1244,1244,AS cohort entry to exposure,0,0
Medicare,No exposure,Infection,Opportunistic infection,1244,1244,12 months,19,1.5273311897
Medicare,No exposure,Infection,Opportunistic infection,1244,1244,24 months,30,2.4115755627
Medicare,No exposure,Infection,Opportunistic infection,1244,1244,36 months,38,3.0546623794
Medicare,No exposure,Infection,Opportunistic infection,1244,1244,AS cohort entry to exposure,1,0.0803858521
Medicare,No exposure,Inflammatory bowel disease,Crohn’s Disease,1244,1244,12 months,40,3.2154340836
Medicare,No exposure,Inflammatory bowel disease,Crohn’s Disease,1244,1244,24 months,50,4.0192926045
Medicare,No exposure,Inflammatory bowel disease,Crohn’s Disease,1244,1244,36 months,53,4.2604501608
Medicare,No exposure,Inflammatory bowel disease,Crohn’s Disease,1244,1244,AS cohort entry to exposure,7,0.5627009646
Medicare,No exposure,Inflammatory bowel disease,Ulcerative Colitis,1244,1244,12 months,27,2.1704180064
Medicare,No exposure,Inflammatory bowel disease,Ulcerative Colitis,1244,1244,24 months,36,2.8938906752
Medicare,No exposure,Inflammatory bowel disease,Ulcerative Colitis,1244,1244,36 months,42,3.3762057878
Medicare,No exposure,Inflammatory bowel disease,Ulcerative Colitis,1244,1244,AS cohort entry to exposure,4,0.3215434084
Medicare,No exposure,Kidney disease,Amyloidosis,1244,1244,12 months,1,0.0803858521
Medicare,No exposure,Kidney disease,Amyloidosis,1244,1244,24 months,2,0.1607717042
Medicare,No exposure,Kidney disease,Amyloidosis,1244,1244,36 months,3,0.2411575563
Medicare,No exposure,Kidney disease,Amyloidosis,1244,1244,AS cohort entry to exposure,0,0
Medicare,No exposure,Kidney disease,IgA nephropathy,1244,1244,12 months,0,0
Medicare,No exposure,Kidney disease,IgA nephropathy,1244,1244,24 months,1,0.0803858521
Medicare,No exposure,Kidney disease,IgA nephropathy,1244,1244,36 months,1,0.0803858521
Medicare,No exposure,Kidney disease,IgA nephropathy,1244,1244,AS cohort entry to exposure,0,0
Medicare,No exposure,Kidney disease,Nephrotic syndrome,1244,1244,12 months,4,0.3215434084
Medicare,No exposure,Kidney disease,Nephrotic syndrome,1244,1244,24 months,5,0.4019292605
Medicare,No exposure,Kidney disease,Nephrotic syndrome,1244,1244,36 months,5,0.4019292605
Medicare,No exposure,Kidney disease,Nephrotic syndrome,1244,1244,AS cohort entry to exposure,0,0
Medicare,No exposure,Lung disease,Interstitial lung disease,1244,1244,12 months,5,0.4019292605
Medicare,No exposure,Lung disease,Interstitial lung disease,1244,1244,24 months,9,0.7234726688
Medicare,No exposure,Lung disease,Interstitial lung disease,1244,1244,36 months,10,0.8038585209
Medicare,No exposure,Lung disease,Interstitial lung disease,1244,1244,AS cohort entry to exposure,0,0
Medicare,No exposure,Lung disease,Restrictive lung disease ,1244,1244,12 months,39,3.1350482315
Medicare,No exposure,Lung disease,Restrictive lung disease ,1244,1244,24 months,55,4.421221865
Medicare,No exposure,Lung disease,Restrictive lung disease ,1244,1244,36 months,75,6.0289389068
Medicare,No exposure,Lung disease,Restrictive lung disease ,1244,1244,AS cohort entry to exposure,0,0
Medicare,No exposure,Neurological Disease,Cauda Equina syndrome,1244,1244,12 months,6,0.4823151125
Medicare,No exposure,Neurological Disease,Cauda Equina syndrome,1244,1244,24 months,6,0.4823151125
Medicare,No exposure,Neurological Disease,Cauda Equina syndrome,1244,1244,36 months,8,0.6430868167
Medicare,No exposure,Neurological Disease,Cauda Equina syndrome,1244,1244,AS cohort entry to exposure,1,0.0803858521
Medicare,No exposure,Neurological Disease,Spinal Cord compression,1244,1244,12 months,3,0.2411575563
Medicare,No exposure,Neurological Disease,Spinal Cord compression,1244,1244,24 months,3,0.2411575563
Medicare,No exposure,Neurological Disease,Spinal Cord compression,1244,1244,36 months,5,0.4019292605
Medicare,No exposure,Neurological Disease,Spinal Cord compression,1244,1244,AS cohort entry to exposure,0,0
Medicare,No exposure,Osteoporotic fracture,Clinical vertebral fracture,1244,1244,12 months,41,3.2958199357
Medicare,No exposure,Osteoporotic fracture,Clinical vertebral fracture,1244,1244,24 months,65,5.2250803859
Medicare,No exposure,Osteoporotic fracture,Clinical vertebral fracture,1244,1244,36 months,88,7.0739549839
Medicare,No exposure,Osteoporotic fracture,Clinical vertebral fracture,1244,1244,AS cohort entry to exposure,3,0.2411575563
Medicare,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1244,1244,12 months,46,3.6977491961
Medicare,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1244,1244,24 months,75,6.0289389068
Medicare,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1244,1244,36 months,98,7.8778135048
Medicare,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1244,1244,AS cohort entry to exposure,1,0.0803858521
Medicare,No exposure,PsO/PsA,Psoriasis,1244,1244,12 months,29,2.3311897106
Medicare,No exposure,PsO/PsA,Psoriasis,1244,1244,24 months,42,3.3762057878
Medicare,No exposure,PsO/PsA,Psoriasis,1244,1244,36 months,45,3.6173633441
Medicare,No exposure,PsO/PsA,Psoriasis,1244,1244,AS cohort entry to exposure,4,0.3215434084
Medicare,No exposure,PsO/PsA,Psoriatic arthritis,1244,1244,12 months,49,3.9389067524
Medicare,No exposure,PsO/PsA,Psoriatic arthritis,1244,1244,24 months,57,4.5819935691
Medicare,No exposure,PsO/PsA,Psoriatic arthritis,1244,1244,36 months,61,4.9035369775
Medicare,No exposure,PsO/PsA,Psoriatic arthritis,1244,1244,AS cohort entry to exposure,12,0.9646302251
Medicare,No exposure,Uveitis,Uveitis,1244,1244,12 months,60,4.8231511254
Medicare,No exposure,Uveitis,Uveitis,1244,1244,24 months,80,6.4308681672
Medicare,No exposure,Uveitis,Uveitis,1244,1244,36 months,85,6.8327974277
Medicare,No exposure,Uveitis,Uveitis,1244,1244,AS cohort entry to exposure,8,0.6430868167
Medicare,TNF,Cancer,Hematologic Cancer,702,810,12 months,5,0.6172839506
Medicare,TNF,Cancer,Hematologic Cancer,702,810,24 months,13,1.6049382716
Medicare,TNF,Cancer,Hematologic Cancer,702,810,36 months,17,2.0987654321
Medicare,TNF,Cancer,Hematologic Cancer,702,810,AS cohort entry to exposure,4,0.4938271605
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,702,810,12 months,19,2.3456790123
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,702,810,24 months,33,4.0740740741
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,702,810,36 months,43,5.3086419753
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,702,810,AS cohort entry to exposure,16,1.975308642
Medicare,TNF,Cancer,Solid Cancer,702,810,12 months,102,12.592592593
Medicare,TNF,Cancer,Solid Cancer,702,810,24 months,122,15.061728395
Medicare,TNF,Cancer,Solid Cancer,702,810,36 months,134,16.543209877
Medicare,TNF,Cancer,Solid Cancer,702,810,AS cohort entry to exposure,74,9.1358024691
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,702,810,12 months,50,6.1728395062
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,702,810,24 months,71,8.7654320988
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,702,810,36 months,81,10
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,702,810,AS cohort entry to exposure,38,4.6913580247
Medicare,TNF,Cardiac disease,Conduction Block,702,810,12 months,48,5.9259259259
Medicare,TNF,Cardiac disease,Conduction Block,702,810,24 months,63,7.7777777778
Medicare,TNF,Cardiac disease,Conduction Block,702,810,36 months,74,9.1358024691
Medicare,TNF,Cardiac disease,Conduction Block,702,810,AS cohort entry to exposure,30,3.7037037037
Medicare,TNF,Cardiac disease,Myocardial infarction,702,810,12 months,11,1.3580246914
Medicare,TNF,Cardiac disease,Myocardial infarction,702,810,24 months,17,2.0987654321
Medicare,TNF,Cardiac disease,Myocardial infarction,702,810,36 months,20,2.4691358025
Medicare,TNF,Cardiac disease,Myocardial infarction,702,810,AS cohort entry to exposure,11,1.3580246914
Medicare,TNF,Infection,Hospitalized infection,702,810,12 months,73,9.012345679
Medicare,TNF,Infection,Hospitalized infection,702,810,24 months,126,15.555555556
Medicare,TNF,Infection,Hospitalized infection,702,810,36 months,155,19.135802469
Medicare,TNF,Infection,Hospitalized infection,702,810,AS cohort entry to exposure,56,6.9135802469
Medicare,TNF,Infection,Opportunistic infection,702,810,12 months,34,4.1975308642
Medicare,TNF,Infection,Opportunistic infection,702,810,24 months,42,5.1851851852
Medicare,TNF,Infection,Opportunistic infection,702,810,36 months,49,6.049382716
Medicare,TNF,Infection,Opportunistic infection,702,810,AS cohort entry to exposure,31,3.8271604938
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,702,810,12 months,41,5.0617283951
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,702,810,24 months,46,5.6790123457
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,702,810,36 months,47,5.8024691358
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,702,810,AS cohort entry to exposure,33,4.0740740741
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,702,810,12 months,36,4.4444444444
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,702,810,24 months,44,5.4320987654
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,702,810,36 months,46,5.6790123457
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,702,810,AS cohort entry to exposure,26,3.2098765432
Medicare,TNF,Kidney disease,IgA nephropathy,702,810,12 months,1,0.1234567901
Medicare,TNF,Kidney disease,IgA nephropathy,702,810,24 months,2,0.2469135802
Medicare,TNF,Kidney disease,IgA nephropathy,702,810,36 months,3,0.3703703704
Medicare,TNF,Kidney disease,IgA nephropathy,702,810,AS cohort entry to exposure,0,0
Medicare,TNF,Kidney disease,Nephrotic syndrome,702,810,12 months,1,0.1234567901
Medicare,TNF,Kidney disease,Nephrotic syndrome,702,810,24 months,1,0.1234567901
Medicare,TNF,Kidney disease,Nephrotic syndrome,702,810,36 months,1,0.1234567901
Medicare,TNF,Kidney disease,Nephrotic syndrome,702,810,AS cohort entry to exposure,0,0
Medicare,TNF,Lung disease,Interstitial lung disease,702,810,12 months,2,0.2469135802
Medicare,TNF,Lung disease,Interstitial lung disease,702,810,24 months,10,1.2345679012
Medicare,TNF,Lung disease,Interstitial lung disease,702,810,36 months,15,1.8518518519
Medicare,TNF,Lung disease,Interstitial lung disease,702,810,AS cohort entry to exposure,4,0.4938271605
Medicare,TNF,Lung disease,Restrictive lung disease ,702,810,12 months,28,3.4567901235
Medicare,TNF,Lung disease,Restrictive lung disease ,702,810,24 months,49,6.049382716
Medicare,TNF,Lung disease,Restrictive lung disease ,702,810,36 months,55,6.7901234568
Medicare,TNF,Lung disease,Restrictive lung disease ,702,810,AS cohort entry to exposure,29,3.5802469136
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,702,810,12 months,1,0.1234567901
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,702,810,24 months,1,0.1234567901
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,702,810,36 months,2,0.2469135802
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,702,810,AS cohort entry to exposure,1,0.1234567901
Medicare,TNF,Neurological Disease,Spinal Cord compression,702,810,12 months,1,0.1234567901
Medicare,TNF,Neurological Disease,Spinal Cord compression,702,810,24 months,2,0.2469135802
Medicare,TNF,Neurological Disease,Spinal Cord compression,702,810,36 months,2,0.2469135802
Medicare,TNF,Neurological Disease,Spinal Cord compression,702,810,AS cohort entry to exposure,1,0.1234567901
Medicare,TNF,Osteoporotic fracture,Clinical vertebral fracture,702,810,12 months,17,2.0987654321
Medicare,TNF,Osteoporotic fracture,Clinical vertebral fracture,702,810,24 months,26,3.2098765432
Medicare,TNF,Osteoporotic fracture,Clinical vertebral fracture,702,810,36 months,32,3.950617284
Medicare,TNF,Osteoporotic fracture,Clinical vertebral fracture,702,810,AS cohort entry to exposure,15,1.8518518519
Medicare,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,702,810,12 months,28,3.4567901235
Medicare,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,702,810,24 months,47,5.8024691358
Medicare,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,702,810,36 months,60,7.4074074074
Medicare,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,702,810,AS cohort entry to exposure,27,3.3333333333
Medicare,TNF,PsO/PsA,Psoriasis,702,810,12 months,37,4.5679012346
Medicare,TNF,PsO/PsA,Psoriasis,702,810,24 months,45,5.5555555556
Medicare,TNF,PsO/PsA,Psoriasis,702,810,36 months,48,5.9259259259
Medicare,TNF,PsO/PsA,Psoriasis,702,810,AS cohort entry to exposure,26,3.2098765432
Medicare,TNF,PsO/PsA,Psoriatic arthritis,702,810,12 months,59,7.2839506173
Medicare,TNF,PsO/PsA,Psoriatic arthritis,702,810,24 months,72,8.8888888889
Medicare,TNF,PsO/PsA,Psoriatic arthritis,702,810,36 months,76,9.3827160494
Medicare,TNF,PsO/PsA,Psoriatic arthritis,702,810,AS cohort entry to exposure,47,5.8024691358
Medicare,TNF,Uveitis,Uveitis,702,810,12 months,57,7.037037037
Medicare,TNF,Uveitis,Uveitis,702,810,24 months,68,8.3950617284
Medicare,TNF,Uveitis,Uveitis,702,810,36 months,78,9.6296296296
Medicare,TNF,Uveitis,Uveitis,702,810,AS cohort entry to exposure,55,6.7901234568
